nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—exocrine gland—esophageal cancer	0.0383	0.143	CbGeAlD
Glucosamine—NFKB2—bronchus—esophageal cancer	0.0242	0.0901	CbGeAlD
Glucosamine—NFKB2—trachea—esophageal cancer	0.0217	0.0809	CbGeAlD
Glucosamine—NFKB2—digestive system—esophageal cancer	0.0187	0.0696	CbGeAlD
Glucosamine—IFNG—epithelium—esophageal cancer	0.0167	0.0621	CbGeAlD
Glucosamine—IFNG—bronchus—esophageal cancer	0.0164	0.0611	CbGeAlD
Glucosamine—MMP9—neck—esophageal cancer	0.0157	0.0586	CbGeAlD
Glucosamine—NFKB2—lung—esophageal cancer	0.0156	0.0582	CbGeAlD
Glucosamine—IFNG—digestive system—esophageal cancer	0.0127	0.0472	CbGeAlD
Glucosamine—TNF—lymph node—esophageal cancer	0.0108	0.0404	CbGeAlD
Glucosamine—MMP9—epithelium—esophageal cancer	0.0107	0.0398	CbGeAlD
Glucosamine—NFKB2—lymph node—esophageal cancer	0.0107	0.0398	CbGeAlD
Glucosamine—IFNG—lung—esophageal cancer	0.0106	0.0394	CbGeAlD
Glucosamine—MMP9—smooth muscle tissue—esophageal cancer	0.0103	0.0384	CbGeAlD
Glucosamine—MMP9—digestive system—esophageal cancer	0.00814	0.0303	CbGeAlD
Glucosamine—IFNG—lymph node—esophageal cancer	0.00724	0.027	CbGeAlD
Glucosamine—MMP9—lung—esophageal cancer	0.0068	0.0253	CbGeAlD
Glucosamine—MMP9—lymph node—esophageal cancer	0.00465	0.0173	CbGeAlD
Glucosamine—CYP2C19—digestive system—esophageal cancer	0.00365	0.0136	CbGeAlD
Glucosamine—CYP2E1—digestive system—esophageal cancer	0.00268	0.00999	CbGeAlD
Glucosamine—CYP2E1—lung—esophageal cancer	0.00224	0.00834	CbGeAlD
Glucosamine—Streptozocin—ABCB1—esophageal cancer	0.000403	1	CrCbGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000317	0.000434	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTO1—esophageal cancer	0.000316	0.000433	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—CYP2A6—esophageal cancer	0.000314	0.00043	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—B2M—esophageal cancer	0.000314	0.00043	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—MYC—esophageal cancer	0.000314	0.000429	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GSTO1—esophageal cancer	0.000312	0.000427	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000312	0.000427	CbGpPWpGaD
Glucosamine—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—esophageal cancer	0.00031	0.000425	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CFL1—esophageal cancer	0.00031	0.000424	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—EGFR—esophageal cancer	0.000307	0.00042	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—RB1—esophageal cancer	0.000299	0.000408	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—PTGS1—esophageal cancer	0.000298	0.000408	CbGpPWpGaD
Glucosamine—IFNG—Immune System—LGALS3—esophageal cancer	0.000297	0.000406	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PSME2—esophageal cancer	0.000297	0.000406	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PSME1—esophageal cancer	0.000297	0.000406	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HSPA5—esophageal cancer	0.000294	0.000402	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KMT2D—esophageal cancer	0.000286	0.000392	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CASP8—esophageal cancer	0.000285	0.00039	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CALR—esophageal cancer	0.000285	0.00039	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TLR4—esophageal cancer	0.000283	0.000388	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CFL1—esophageal cancer	0.00028	0.000382	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—KDR—esophageal cancer	0.000276	0.000378	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—FBXW7—esophageal cancer	0.000275	0.000377	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MET—esophageal cancer	0.00027	0.000369	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—SOX2—esophageal cancer	0.00027	0.000369	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—EGFR—esophageal cancer	0.000266	0.000364	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—PTGS2—esophageal cancer	0.000265	0.000363	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ACTB—esophageal cancer	0.000264	0.00036	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HMGB1—esophageal cancer	0.000263	0.00036	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP8—esophageal cancer	0.000262	0.000358	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ABL1—esophageal cancer	0.00026	0.000356	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000259	0.000354	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—ALDH2—esophageal cancer	0.000258	0.000353	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—esophageal cancer	0.000258	0.000353	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTPN2—esophageal cancer	0.000257	0.000352	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ADCYAP1—esophageal cancer	0.000255	0.000349	CbGpPWpGaD
Glucosamine—IFNG—Immune System—B2M—esophageal cancer	0.000254	0.000348	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—CYP1B1—esophageal cancer	0.000253	0.000347	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MYC—esophageal cancer	0.000252	0.000345	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—SMAD4—esophageal cancer	0.000252	0.000344	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—esophageal cancer	0.000251	0.000344	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—CYP1B1—esophageal cancer	0.00025	0.000342	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTT1—esophageal cancer	0.000245	0.000336	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CASP8—esophageal cancer	0.000245	0.000335	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CASP8—esophageal cancer	0.000243	0.000332	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP2A6—esophageal cancer	0.000243	0.000332	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CREBBP—esophageal cancer	0.000242	0.000331	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PSME2—esophageal cancer	0.00024	0.000329	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PSME1—esophageal cancer	0.00024	0.000329	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CCND1—esophageal cancer	0.00024	0.000328	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—CYP19A1—esophageal cancer	0.000238	0.000326	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HSPA5—esophageal cancer	0.000238	0.000326	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ACTB—esophageal cancer	0.000238	0.000325	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000237	0.000324	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000235	0.000321	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—WWOX—esophageal cancer	0.000234	0.000319	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CTNNA1—esophageal cancer	0.000234	0.000319	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—PIK3CA—esophageal cancer	0.000231	0.000316	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CALR—esophageal cancer	0.000231	0.000316	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—PTGS1—esophageal cancer	0.00023	0.000315	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—BCL2—esophageal cancer	0.000224	0.000307	CbGpPWpGaD
Glucosamine—IFNG—Immune System—FBXW7—esophageal cancer	0.000223	0.000305	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FKBP1A—esophageal cancer	0.000222	0.000304	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000221	0.000303	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.00022	0.000301	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ABL1—esophageal cancer	0.000218	0.000298	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—esophageal cancer	0.000218	0.000298	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—PIK3CA—esophageal cancer	0.000217	0.000297	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—WIF1—esophageal cancer	0.000217	0.000297	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—CDKN1A—esophageal cancer	0.000215	0.000293	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—esophageal cancer	0.000214	0.000293	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HMGB1—esophageal cancer	0.000213	0.000292	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—BCL2—esophageal cancer	0.000209	0.000285	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—esophageal cancer	0.000207	0.000283	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB2—esophageal cancer	0.000203	0.000277	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CSNK1A1—esophageal cancer	0.0002	0.000274	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—ERBB2—esophageal cancer	0.000197	0.00027	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—KDR—esophageal cancer	0.000197	0.000269	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP1B1—esophageal cancer	0.000196	0.000267	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000193	0.000264	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MET—esophageal cancer	0.000193	0.000264	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MYC—esophageal cancer	0.000192	0.000263	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.00019	0.00026	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000189	0.000258	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—EGFR—esophageal cancer	0.000188	0.000257	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PFN1—esophageal cancer	0.000187	0.000256	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NOTCH1—esophageal cancer	0.000186	0.000254	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000184	0.000252	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—CYP19A1—esophageal cancer	0.000184	0.000251	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—PIK3CA—esophageal cancer	0.000183	0.000251	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000181	0.000248	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.00018	0.000247	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000176	0.000241	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ABL1—esophageal cancer	0.000176	0.000241	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—PIK3CA—esophageal cancer	0.000176	0.000241	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CDKN1A—esophageal cancer	0.000173	0.000237	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ELMO1—esophageal cancer	0.000168	0.00023	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—CREBBP—esophageal cancer	0.000168	0.00023	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR4—esophageal cancer	0.000165	0.000226	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EP300—esophageal cancer	0.000165	0.000225	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—AKAP13—esophageal cancer	0.000165	0.000225	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000163	0.000223	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ABL1—esophageal cancer	0.000159	0.000218	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—esophageal cancer	0.000158	0.000216	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000158	0.000216	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—SMAD4—esophageal cancer	0.000154	0.000211	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000152	0.000208	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PDE4D—esophageal cancer	0.00015	0.000206	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.00015	0.000205	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MYC—esophageal cancer	0.000145	0.000198	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GNG7—esophageal cancer	0.000143	0.000196	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—esophageal cancer	0.000143	0.000196	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—EGFR—esophageal cancer	0.000142	0.000194	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CASP8—esophageal cancer	0.000142	0.000194	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CREBBP—esophageal cancer	0.000141	0.000193	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—ERBB2—esophageal cancer	0.000141	0.000193	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—EGFR—esophageal cancer	0.00014	0.000192	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—EGFR—esophageal cancer	0.000137	0.000187	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—XIAP—esophageal cancer	0.000134	0.000183	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR4—esophageal cancer	0.000134	0.000183	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000131	0.000179	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—BLVRB—esophageal cancer	0.000128	0.000175	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC52A3—esophageal cancer	0.000128	0.000175	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000128	0.000175	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000127	0.000174	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—esophageal cancer	0.000127	0.000174	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CTNNA1—esophageal cancer	0.000127	0.000174	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL2—esophageal cancer	0.000126	0.000173	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—PIK3CA—esophageal cancer	0.000122	0.000167	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—BCL2—esophageal cancer	0.000121	0.000166	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—KDR—esophageal cancer	0.000121	0.000165	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—esophageal cancer	0.000119	0.000163	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB2—esophageal cancer	0.000118	0.000161	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MET—esophageal cancer	0.000118	0.000161	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PSME2—esophageal cancer	0.000118	0.000161	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PSME1—esophageal cancer	0.000118	0.000161	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ANXA1—esophageal cancer	0.000117	0.00016	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CASP8—esophageal cancer	0.000115	0.000157	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EP300—esophageal cancer	0.000115	0.000157	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CREBBP—esophageal cancer	0.000114	0.000156	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SST—esophageal cancer	0.000114	0.000156	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NOTCH1—esophageal cancer	0.000114	0.000155	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GHRL—esophageal cancer	0.000111	0.000152	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOTCH3—esophageal cancer	0.000111	0.000152	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000111	0.000152	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000111	0.000152	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FBXW7—esophageal cancer	0.000109	0.00015	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CA1—esophageal cancer	0.000109	0.000149	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC10A2—esophageal cancer	0.000109	0.000149	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000107	0.000147	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—CREBBP—esophageal cancer	0.000103	0.000141	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CDKN1A—esophageal cancer	0.000101	0.000138	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOTCH2—esophageal cancer	9.97e-05	0.000136	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CA2—esophageal cancer	9.96e-05	0.000136	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—BLVRB—esophageal cancer	9.88e-05	0.000135	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC52A3—esophageal cancer	9.88e-05	0.000135	CbGpPWpGaD
Glucosamine—IFNG—Immune System—BCL2—esophageal cancer	9.84e-05	0.000135	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—EGFR—esophageal cancer	9.77e-05	0.000134	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EP300—esophageal cancer	9.6e-05	0.000131	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB2—esophageal cancer	9.56e-05	0.000131	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLCE1—esophageal cancer	9.26e-05	0.000127	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ADH7—esophageal cancer	9.26e-05	0.000127	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFBR2—esophageal cancer	8.84e-05	0.000121	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	8.83e-05	0.000121	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ERBB2—esophageal cancer	8.63e-05	0.000118	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC10A2—esophageal cancer	8.4e-05	0.000115	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CA1—esophageal cancer	8.4e-05	0.000115	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SMAD4—esophageal cancer	8.37e-05	0.000115	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—EGFR—esophageal cancer	8.18e-05	0.000112	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CDKN1A—esophageal cancer	8.17e-05	0.000112	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ADH1B—esophageal cancer	8.12e-05	0.000111	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EP300—esophageal cancer	7.78e-05	0.000106	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TYMP—esophageal cancer	7.76e-05	0.000106	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CA2—esophageal cancer	7.68e-05	0.000105	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP26A1—esophageal cancer	7.55e-05	0.000103	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	7.51e-05	0.000103	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALOX15—esophageal cancer	7.35e-05	0.000101	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLCE1—esophageal cancer	7.14e-05	9.77e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ADH7—esophageal cancer	7.14e-05	9.77e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PIK3CA—esophageal cancer	7.1e-05	9.71e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	7.06e-05	9.66e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EP300—esophageal cancer	7.02e-05	9.6e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTO1—esophageal cancer	7.01e-05	9.6e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TPI1—esophageal cancer	7.01e-05	9.6e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—HIF1A—esophageal cancer	6.85e-05	9.37e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALDOB—esophageal cancer	6.73e-05	9.2e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—EGFR—esophageal cancer	6.63e-05	9.07e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—KDR—esophageal cancer	6.55e-05	8.96e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GAPDH—esophageal cancer	6.47e-05	8.86e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CRABP1—esophageal cancer	6.42e-05	8.78e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ADH1B—esophageal cancer	6.26e-05	8.57e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOTCH1—esophageal cancer	6.17e-05	8.44e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GNG7—esophageal cancer	6.1e-05	8.35e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TYMP—esophageal cancer	5.98e-05	8.19e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—EGFR—esophageal cancer	5.98e-05	8.18e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	5.82e-05	7.96e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PIK3CA—esophageal cancer	5.75e-05	7.87e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALDH2—esophageal cancer	5.72e-05	7.82e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALOX15—esophageal cancer	5.67e-05	7.76e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CREBBP—esophageal cancer	5.59e-05	7.65e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTT1—esophageal cancer	5.44e-05	7.44e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTO1—esophageal cancer	5.41e-05	7.4e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TPI1—esophageal cancer	5.41e-05	7.4e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP2A6—esophageal cancer	5.38e-05	7.35e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALDOB—esophageal cancer	5.19e-05	7.1e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ENO1—esophageal cancer	5.1e-05	6.97e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS1—esophageal cancer	5.1e-05	6.97e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PSME1—esophageal cancer	5.02e-05	6.87e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PSME2—esophageal cancer	5.02e-05	6.87e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOS3—esophageal cancer	5.01e-05	6.85e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GAPDH—esophageal cancer	4.99e-05	6.83e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CRABP1—esophageal cancer	4.95e-05	6.77e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GNG7—esophageal cancer	4.71e-05	6.44e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB2—esophageal cancer	4.69e-05	6.41e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALDH2—esophageal cancer	4.41e-05	6.03e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP1B1—esophageal cancer	4.33e-05	5.93e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTT1—esophageal cancer	4.2e-05	5.74e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	4.15e-05	5.67e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCND1—esophageal cancer	4.14e-05	5.66e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.13e-05	5.65e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CYP19A1—esophageal cancer	4.07e-05	5.57e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CDKN1A—esophageal cancer	4e-05	5.48e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ENO1—esophageal cancer	3.93e-05	5.38e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS1—esophageal cancer	3.93e-05	5.38e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PSME2—esophageal cancer	3.87e-05	5.3e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PSME1—esophageal cancer	3.87e-05	5.3e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EP300—esophageal cancer	3.81e-05	5.21e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—HMOX1—esophageal cancer	3.72e-05	5.09e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ABCB1—esophageal cancer	3.57e-05	4.88e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.38e-05	4.63e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	3.34e-05	4.57e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MYC—esophageal cancer	3.32e-05	4.54e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—EGFR—esophageal cancer	3.25e-05	4.44e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	3.14e-05	4.3e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—HMOX1—esophageal cancer	2.87e-05	3.92e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PIK3CA—esophageal cancer	2.82e-05	3.86e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.81e-05	3.85e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ABCB1—esophageal cancer	2.75e-05	3.77e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—esophageal cancer	2.73e-05	3.73e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CREBBP—esophageal cancer	2.39e-05	3.26e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NOS3—esophageal cancer	2.14e-05	2.92e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.08e-05	2.85e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—esophageal cancer	1.95e-05	2.67e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CREBBP—esophageal cancer	1.84e-05	2.52e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NOS3—esophageal cancer	1.65e-05	2.25e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—EP300—esophageal cancer	1.62e-05	2.22e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—esophageal cancer	1.51e-05	2.06e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—EP300—esophageal cancer	1.25e-05	1.71e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PIK3CA—esophageal cancer	1.2e-05	1.64e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	9.27e-06	1.27e-05	CbGpPWpGaD
